PRKCH has been shown to regulate cancer cell proliferation and increase chemotherapy resistance in a variety of cancers, including glioblastoma 64, breast cancer 65, and non-small cell lung cancer 66. This evidence concerns the gene PRKCH and non-small cell lung carcinoma.